WO2023227941 - PRE-DOSING METHOD OF ASSESSING DRUG BENEFITS IN PATIENTS
National phase entry:
Publication Number
WO/2023/227941
Publication Date
30.11.2023
International Application No.
PCT/IB2023/000292
International Filing Date
22.05.2023
Title **
[English]
PRE-DOSING METHOD OF ASSESSING DRUG BENEFITS IN PATIENTS
[French]
PROCÉDÉ DE PRÉ-DOSAGE POUR ÉVALUER DES BÉNÉFICES DE MÉDICAMENT CHEZ DES PATIENTS
Applicants **
DIAMOND THERAPEUTICS INC.
Inventors
BLUMSTOCK, Judith
TYLER, William, James
Priority Data
63/344,939
23.05.2022
US
63/387,769
16.12.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3621 | |
| EPO | Filing, Examination, Granting | 26089 | |
| Japan | Filing, Examination, Granting | 2858 | |
| South Korea | Filing, Examination, Granting | 3584 | |
| USA | Filing, Examination, Granting | 9190 |
Total:
45,342
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed herein are methods of treatment and methods of evaluating individuals to identify and measure biomarkers and/or states of the individuals indicative of drug responsiveness to one or more 5-HT receptor agonist.[French]
L'invention concerne des procédés de traitement et des procédés d'évaluation d'individus pour identifier et mesurer des biomarqueurs et/ou des états des individus indiquant la réactivité d'un médicament à un ou plusieurs agonistes du récepteur 5-HT.